Dr. Anna Yemelyanova
Assistant Professor, Pathology
My research interests include clinic-pathologic, immunohistochemical, and molecular characterization of endometrial cancer. I am currently studying various immunohistochemical markers that may assist in pathologic diagnosis of these tumors and further explore their pathogenesis. The other area of my interest concerns cervical cancer related to high risk human papillomavirus (HPV); I am investigating viral protein expression as potential biomarkers useful in diagnosis and clinical management of pre-malignant cervical lesions.
Yemelyanova A, Vang RS, Judson K, Wu LS, Ronnett BM; Distinction of Primary and Metastatic Mucinous Tumors Involving the Ovary: Analysis of Size and Laterality Data by Primary Site with Re-evaluation of an Algorithm for Tumor Classification Am J Surg Pathol, 2008; 32(1): 128-38.
Yemelyanova A, Cosin J, Bidus MA Boice CR, Seidman JD; Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008; 18(3):465-9.
Yemelyanova A, Mao TL, Nakayama N, Shih IM, Kurman RJ: Low-grade Serous Carcinoma of the Ovary Displaying a Macropapillary Pattern of Invasion. Am J Surg Pathol 2008; 32(12):1800-6.
Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Endocervical Adenocarcinomas With Prominent Endometrial or Endomyometrial Involvement Simulating Primary Endometrial Carcinomas: Utility of HPV DNA Detection and Immunohistochemical Expression of p16 and Hormone Receptors to Confirm the Cervical Origin of the Corpus Tumor. Am J Surg Pathol, 2009; 33(6):914-24.
Yemelyanova A, Ji H, Shih IM, Wang TL, Wu LS, Ronnett BM; Utility of p16 Expression for Distinction of Uterine Serous Carcinomas from Endometrial Endometrioid and Endocervical Adenocarcinomas: Immunohistochemical Analysis of 201 Cases. Am J Surg Pathol (E-pub, 2009).